The use of monoamineoxidase inhibitors in the treatment of depression is increasing again in Australia. This paper outlines changes in prescribing, the problems associated with monoamineoxidase (MAO) inhibitors and how they relate to the practice of anaesthesia.
References
1.
BodleyP. O., HalmaxK., and PottsL. (1969): “Low serum cholinesterase levels complicating treatment with phenelzine”, Brit. Med. J., 3, 510.
2.
BrownT. C. K., and CassN. M. (1970): “Pharmacological basis of drug interactions”, Aust. N.Z. J. Surg., 41, 79.
3.
Churchill DavidsonH. C. (1965): “Anaesthesia and MAO inhibitors”, Brit. Med. J., 1, 520.
4.
DentonP. H., BorrellV. M., and EdwardsN. V. (1962): “Dangers of MAO inhibitors”, Brit. Med. J., 2, 1752.
5.
GoldbergL. I. (1964): “Monoamine oxidase inhibitors — adverse reactions and possible mechanisms”, J. Amer. Med. Ass., 190, 456.
6.
Jenkins and Graves (1965): “Potential hazards of psychoactive drugs in association with anaesthesia”,Canad. Anaesth. Soc. J., 12, 121.
7.
McGilchristJ. M. (1975): “Interactions between MAO inhibitors”, Brit. Med. J., 3, 591.
8.
PalmerH. (1960): “Potentiation of pethidine”, Brit. Med. J., 2, 944.
9.
PappC., and BenaimS. (1958): “Toxic effects of Iproniazid in a patient with angina”, Brit. Med. J., 2, 1070.
10.
Pell-CocksD., and Passmore RoweA. (1962): “Dangers of MAO inhibitors”, Brit. Med. J., 2, 1545.
11.
PennR. G., and RogersK. J. (1971): “Comparison of the effects of morphine, pethidine and pentazocine in rabbits pretreated with an MAO”, Brit. J. Pharmacol., 42, 485.
12.
ReidN. C. R. W., and JonesD. (1962): “Pethidine and phenelzine”, Brit. Med. J., 1, 408.
13.
RogersK. J., and ThorntonJ. A. (1969): “Interactions between MAO inhibitors and narcotic analgesics in mice”, Brit. J. Pharmacol., 36, 470.
14.
SargantW. (1975): “Interactions with MAO inhibitors”, Brit. Med. J., 3, 510.
15.
StockleyI. (1974): “Monoamineoxidase inhibitors”.Drug interactions and their mechanisms.Pharmaceutical Press, London, p. 60–62.
16.
TaylorD. C. (1962): “Alarming reactions to pethidine in patients on phenelzine”, Lancet, 2, 401.
17.
VickersM. D. (1965): “Anaesthesia and MAO inhibitors”, Brit. Med. J., 1, 1126.
18.
WulfsonN. L., and PolitzerW. M. (1962): 5-Hydroxytryptamine in anaesthesia”, Anaes., 17, 64.
